A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...
The rising incidence of chronic diseases like diabetes, which call for regular blood glucose testing, is driving the demand for the lancets market.<p ...
The decisions that policymakers make could leave many millions of people much worse off while extending and increasing tax ...
Below is a roundup of payer-centric news headlines you may have missed during the month of January 2025. | You may have ...
The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by ...
The global companion animal diagnostics market is projected to reach US$ 4.55 Billion by 2029 from US$ 2.99 Billion in 2024 ...
Everyone, regardless of income, needs health care to survive and thrive, and most Americans agree that health care is a ...
USA Patient Registry Software is expected to show increasing and is expected to grow at a CAGR of ~$% from 2022 to 2028 because of the Government initiatives & technological advancements leading to ...
Diabetes is a leading cause of global mortality and disability, and its economic burden is substantial. This Review focuses on type 2 diabetes, which makes up 90–95% of all diabetes cases. Type 2 ...
News Medical on MSN5d
AI-powered glucose analysis: GPT-4 offers promise with room for refinementGPT-4 demonstrates its potential in analyzing continuous glucose monitoring data, offering accurate metrics and summaries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback